Precision radiation plus immunotherapy shows promise for bile duct cancer
Disease control
Recruiting now
This study tests a new approach for advanced bile duct cancer, combining a precise type of radiation (PULSAR) with immunotherapy drugs and chemotherapy. The goal is to see if this combination is safe and effective. The trial is recruiting 60 adults aged 18-75 with confirmed bile …
Phase: PHASE1, PHASE2 • Sponsor: Wang Xin • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC